Konstantinos Andrikopoulos

Konstantinos Andrikopoulos has a diverse work experience in the field of intellectual property. Konstantinos is currently serving as the SVP of Intellectual Property at Tome Biosciences since August 2022. Konstantinos previously worked at Vertex Pharmaceuticals as the Executive Director of IP from July 2017 to August 2022. Prior to that, they worked at Biogen as an IP Counsel from June 2010 to July 2017. Konstantinos also held the position of VP, Legal Counsel & Chief IP Counsel at RXi Pharmaceuticals from November 2008 to August 2010. Before joining RXi Pharmaceuticals, they worked at Shire Pharmaceuticals as a Senior Patent Counsel from September 2002 to November 2008. Konstantinos started their career as an Associate at Wolf Greenfield, where they worked from 1997 to 2002.

Konstantinos Andrikopoulos completed their Ph.D. degree in Molecular Biology & Genetics from the Icahn School of Medicine at Mount Sinai between the years 1989 and 1994. Later, they pursued further education at Suffolk University Law School, where they obtained a Doctor of Law (J.D.) degree from 1997 to 2001.